Abstract
Two chemotherapy regimens for intermediate- and poor-risk metastatic nonseminomatous germ cell tumors were compared for efficacy and toxicity. From February 1994 to February 2000, 190 patients were randomly assigned between either four cycles of BEP (bleomycin 30 mg d1, d8, d15; etoposide 100 mg/m(2) d1-5; cisplatin 20 mg/m(2) d1-5) or four to six alternating cycles of CISCA/VB (cyclophosphamide 400 mg/m(2) d1-2, doxorubicin 35 mg/m(2) d1-2, cisplatin 100 mg/m(2) d3/vinblastine 2.5 mg/m(2) d1-5, bleomycin 25 mg/m(2) d1-5). Risk was initially defined according to the Institut Gustave Roussy (Villejuif, France) prognostic model based on serum alpha-fetoprotein and human chorionic gonadotropin levels only. Patients were retrospectively assigned into the International Germ Cell Consensus Classification. Among 185 assessable patients, favorable responses did not differ statistically between the two arms: 49 in the CISCA/VB arm (56%; 95% CI, 45% to 66%), 57 in the BEP arm (65%; 95% CI, 55% to 75%). The CISCA/VB regimen induced more significant hematologic and mucous toxicities compared with the BEP arm. The 5-year event-free survival rates were 37% (95% CI, 27% to 47%) and 47% (95% CI, 37% to 57%) in CISCA/VB and BEP arms, respective...Continue Reading
References
Nov 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·L H Einhorn
Jul 1, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C R NicholsL H Einhorn
Aug 1, 1986·The American Journal of Medicine·C J LogothetisA von Eschenbach
Jun 4, 1987·The New England Journal of Medicine·S D WilliamsP J Loehrer
Aug 1, 1988·Cancer·J P DrozJ P Travagli
Mar 1, 1985·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C J LogothetisA C von Eschenbach
Mar 1, 1984·Cancer·M K SamsonG D Cummings
Jan 1, 1981·Cancer·A B MillerA Winkler
Jun 1, 1995·British Journal of Cancer·R de WitR Sylvester
Jan 1, 1993·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J P DrozJ L Pico
Feb 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Apr 1, 1997·American Journal of Clinical Oncology·S CulineJ P Droz
Jul 24, 1997·The New England Journal of Medicine·G J Bosl, R J Motzer
Jan 1, 1997·Clinical Oncology : a Journal of the Royal College of Radiologists·G M Mead, S P Stenning
Feb 20, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S B KayeP deMulder
Apr 29, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C R NicholsP J Loehrer
Sep 22, 1998·British Journal of Cancer·R de WitR Sylvester
Feb 28, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·K FizaziR J Amato
Apr 4, 2003·Cancer·Stuart HintonPatrick J Loehrer
Aug 11, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Karim FizaziChristopher J Logothetis
Aug 21, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H J SchmollUNKNOWN European Germ Cell Cancer Consensus Group
Nov 7, 2006·European Urology·Jean-Pierre DrozUNKNOWN Genito-Urinary Group of the French Federation of Cancer Centers (GETUG)
Jan 20, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert J MotzerGeorge J Bosl
Citations
Mar 3, 2009·Der Urologe. Ausg. A·A HeidenreichR Souchon
Mar 31, 2009·World Journal of Urology·Matthew J Riese, David J Vaughn
Apr 9, 2013·Apoptosis : an International Journal on Programmed Cell Death·Denis SelimovicMohamed Hassan
Jun 19, 2012·Current Oncology Reports·Alison J Moskowitz
Feb 26, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C MassardK Fizazi
Apr 14, 2009·Current Opinion in Oncology·Heather D Mannuel, Arif Hussain
Sep 23, 2010·AJR. American Journal of Roentgenology·Atul B ShinagareAnnick D Van den Abbeele
Dec 21, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P S GrimisonUNKNOWN Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Jun 26, 2013·BJU International·Mariam Jamal-HanjaniSimon Chowdhury
Nov 20, 2009·Cancer Science·Koji Kawai, Hideyuki Akaza
Jun 5, 2014·Internal Medicine Journal·J LewinG Toner
Feb 6, 2015·International Journal of Clinical Oncology·Naotaka NishiyamaNaoya Masumori
Sep 4, 2012·Asian Pacific Journal of Cancer Prevention : APJCP·Muhammad AzrifFuad Ismail
Dec 2, 2008·Cases Journal·Nabil IsmailiHassan Errihani
Mar 27, 2015·PloS One·Sven-Erik OlofssonMats Jerkeman
Apr 5, 2011·Urologic Oncology·Eva GiesenJ Martijn Kerst
Feb 21, 2006·Journal of Clinical Epidemiology·Merel R van DijkJ Dik F Habbema
May 17, 2011·Hematology/oncology Clinics of North America·Craig Nichols, Christian Kollmannsberger
Feb 16, 2019·Pediatric Blood & Cancer·Mohammad H Abu ArjaMohamed S AbdelBaki
Aug 8, 2008·Current Opinion in Supportive and Palliative Care·Tina Cheng
Oct 21, 2009·BJU International·Gedske Daugaard
Dec 1, 2010·Nature Reviews. Endocrinology·Christian Winter, Peter Albers
Nov 1, 2013·ISRN Rheumatology·Sergio A Jimenez
Apr 13, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sven-Erik OlofssonEva Cavallin-Ståhl
Feb 22, 2017·Current Oncology Reports·J Clayton AllenAlicia K Morgans
Oct 7, 2018·Nature Reviews. Disease Primers·Liang ChengLeendert H J Looijenga
Oct 28, 2016·The Journal of Obstetrics and Gynaecology Research·Makiko HinoHiroyuki Nakagawa
Oct 27, 2015·American Journal of Physiology. Lung Cellular and Molecular Physiology·Biji MathewJeffrey R Jacobson
Feb 3, 2020·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Fay H CaffertyUNKNOWN TE23 Trial Management Group and Collaborators
May 13, 2021·Journal of Pediatric Surgery·Jennifer H AldrinkPeter F Ehrlich
Jun 3, 2021·Cancers·Mariana Tomazini PintoLuiz Fernando Lopes
Jun 15, 2021·Frontiers in Oncology·Axel S MerseburgerPetra Pichler